Oct

18

Just as I Said Before, Isonic Corp (Symbol: ISON) Has Finally Hit $5.48/Share

Filed Under Chemical Manufacturing | Leave a Comment

…Yes, that’s 62% increase, by the way. Went up by $2.11 in just one day. They even went up as high as $6.27/share until it finally settled at $5.48/share when the market closed.

If you go back to the blog that I wrote last Friday, I was predicting that this stock was going to hit $5/share by the end of the year. Well I guess I was wrong…It’s already more than $5/share now. And I think it’s going to keep going up – especially since they’re going to do public demonstration on their product on October 21st. If you want to invest in this company, I’d (again) strongly suggest to invest at this moment – before they’re doing public presentation on their product. Because I have a hunch that the price is going through the roof after the demonstration.

Would you like me refresh your memory again what they’re doing? Here it is:

Isonics Corporation has three business divisions: (1) Isonics Semiconductor, (2) Isonics Life Sciences, and (3) Homeland Security and Defense. Isonics is a world leader in isotopically engineered materials and through its semiconductor division produces isotopically pure silicon-28 chemicals and wafers for the semiconductor industry. Through advances in nanotechnology, the Company is also focused on research and development opportunities for further, value-added product and application development. Isonics’ Life Sciences division markets and sellsstable isotopes for the health care industry such as carbon-13 for diagnostic breath tests and drug design, and radioisotopes and stable isotopes, such as oxygen-18 for positron emission tomography (PET) imaging. (Source Business Wire 2004)

And here’s the product that they’re going to present on October 21st:

The NeutroTest(TM) product is a portable, hand-held device designed to provide first-responders with a powerful tool for quickly and easily evaluating an explosive threat in the form of a suspicious package or purported explosive device. It was designed to be capable of detecting as little as 200 grams of TNT or other explosive material through 5 mm of steel.

This neutron-based technology is distinct from the x-ray scanning systems commonly used in package and suitcase security inspections, and provides unique types of information about the packages or cases being evaluated. X-rays simply detect shapes and density, and provide pictures of the contents of containers. Neutrons have the ability to provide information regarding the nature of the chemical composition while x-rays do not.

Isonics is positioning the NeutroTest(TM) as a moderately-priced, portable product for use by first-responders in bomb squads, airports, police departments, fire departments, customs agencies and security services worldwide. (Source: Business Wire 2004)

Remember! You invest in this company because of the product that they offer. Not because the stock is going up. The product is released at the right time, and yes there is huge market for their product. Think about it…

Quote of the Day:
The dumbest reason in the world to buy a stock is because it’s going up. – Warren Buffett

  • Share/Bookmark

Oct

17

Austin Medical Technologies Inc. (Symbol: AMTK)

Filed Under Medical Equipment & Supplies | Leave a Comment

Came accross this company when I did my research last weekend. They used to be traded as high as $0.50/share. Then it’s been going down drastically and currently it’s traded at $0.05/share. I’m not really sure if the stock is going to perform well sometime in the near future, but looks like the company is doing pretty well. Thought I’d post it here maybe someone will be interested in invest in this company since the price/share is really low.

About the company?
Austin Medical Technologies delivers “DIRECT” from the manufacturer to the Surgeon, the only technology based, “Single Source Supply Solution” for custom sterile surgery trays made up of 80% of all disposable surgical devices utilized in surgery. Currently the company has contracted with 200 eye surgery centers including the 2 largest eye surgery centers in the USA. The market for custom sterile surgery trays is a $2.1 Billion market here in the USA.

Austin Medical is dedicated exclusively to the Ambulatory Surgery Center (ASC) market. Ambulatory Surgery Centers (ASC), also called outpatient surgery, and same-day surgery, refers to surgical procedures which are complex enough to require a dedicated operating room and specially trained staff, but do not require an overnight stay. According to 1996 U.S. government statistics, ambulatory surgery centers account for 31 million or 44% of the total surgeries performed in the United States. Five million surgeries were performed on eyes. New surgical techniques such as laser surgery allow procedures to be done more quickly and/or with less surgical trauma.

Under the brand name eyeDirecti, Austin Medical is initially focused on Ophthalmology owned and operated surgery centers which is the fastest growing segment of the ASC market, growing by 25% per annum, consisting of 2,500 practices with 15,000 surgeons performing over 5 million surgical procedures annually at a supply cost of $400,000,000 per year. (Source: Yahoo News)

Recently they just had a press release saying that they have just added 14 new customers in the 3rd quarter, adding new sales of $1.1 million over the contracted period. And one more thing, Austin Medical is positioned to capture $40,000,000 (10%) of this $400,000,000 market within the next 4 years. As I’ve said before, I’m pretty sceptical if this stock is going to perform well, but looks like if you look at the company profile and the industry, the company is surely going to be doing well in the future. We’ll see about this. I’m going to be watching this company very closely for the next few months.

Quote of the Day:
If we find a company we like, the level of the market will not really impact our decisions. We will decide company by company. We spend essentially no time thinking about macroeconomic factors. – Warren Buffett

  • Share/Bookmark

Oct

15

Isonic Corporation – Wish I Had Invested in This Company Earlier

Filed Under Chemical Manufacturing | Leave a Comment

Damn…Should’ve invested my money in this company when I had a chance!
Ugh well…But then again, I was a little bit broke when I first heard the news…
On October 8th, 2004, Isonic Corporation (Symbol: ISON) released a statement saying that they will serve worldwide demand for anti-terror solutions with next-generation technologies and products. First, let me tell you a little bit about this company.

Isonic Corporation has three business divisions:
(1) Isonics Semiconductor
(2) Isonics Life Sciences
(3) Homeland Security and Defense
Isonics is a world leader in isotopically engineered materials and through its semiconductor division produces isotopically
pure silicon-28 chemicals and wafers for the semiconductor industry. Through advances in nanotechnology, the Company is also focused on research and development opportunities for further, value-added product and application development. Isonics’ Life Sciences division markets and sells stable isotopes for the health care industry such as carbon-13 for diagnostic breath tests and drug design, and radioisotopes and stable isotopes, such as oxygen-18 for positron emission tomography (PET) imaging. (Source: Business Wire 2004)

Sounds interesting? At that time, the stock was traded around $2.50/share.

Today, they released another statement saying that they have scheduled the premier public demonstration of a prototype of its NeutroTest(TM) explosive detection product. The presentation, which will be available to the public via the Internet, has been scheduled for Noon EDT, October 21.

Do you know anything about NeuroTest explosive detection product?

The NeutroTest(TM) product is a portable, hand-held device designed to provide first-responders with a powerful tool for quickly and easily evaluating an explosive threat in the form of a suspicious package or purported explosive device. It was designed to be capable of detecting as little as 200 grams of TNT or other explosive material through 5 mm of steel. The NeutroTest(TM) device uses a stream of neutrons to penetrate
to the interior of objects, such as packages or suitcases, and interact with the materials inside. When interacting with neutrons, every element produces a unique data “signature,” consisting of back-scattered neutrons, gamma rays and other information. NeutroTest(TM) analyzes the data streams and informs the operator viaa readable display if the contents are potentially dangerous.
This neutron-based technology is distinct from the x-ray scanning systems commonly used in package and suitcase security inspections, and provides unique types of information about the packages or cases being evaluated. X-rays simply detect shapes and density, and provide pictures of the contents of containers. Neutrons have the ability to provide information regarding the nature of the chemical composition while x-rays do not. (Source: Yahoo News)

Pretty fancy, huh? :-)

Yupp, sure enough…After this statement was released, the price/share went up by $1.19 and currently it’s traded at $3.37/share. I have a feeling that this one is going to hit $5/share by the end of the year. If you happen to have a couple of hundred dollars to spare, I’d strongly suggest to invest in this company. They were also saying that their product, hand-held NeutroTest(TM), will give first-responders a portable tool for quickly and easily evaluating an explosive threat in the form of a suspicious package or purported explosive device. Isonics believes that this modestly priced product may become an essential tool for bomb squads, police departments, fire departments, customs agencies and security services worldwide.
Still not convinced?

Quote of the Day:
Valuing a business is part art and part science. – Warren Buffett

  • Share/Bookmark

Oct

12

DNAPrint Genomics Inc. (Symbol: DNAP)

Filed Under Biotechnology & Drugs | Leave a Comment

Last week I just purchased 3,000 shares of DNAPrint Genomic Inc. (Symbol: DNAG). Didn’t really cost me a lot of money since it’s traded around 1 cents/share. Want to know why did I invest in this company? Well…Let me tell you a little bit information about this company.

DNAPrint Genomic Inc. is a genomics science company, focusing on the sale of unique proprietary genetic testing products and services. They are currently focusing their efforts in four distinct markets:
1. Pharmacogenomics Market
The testing of individuals to predict their genetic predisposition to drug response is known as pharmacogenomics. Pharmacogenomics enables physicians to tailor drug therapies (formulation and dosage) for individuals based on their genetic composition, increasing rates of therapeutic success and decreasing rates of adverse side effects. Drug discovery companies are beginning to use pharmacogenomics technologies to develop drugs that are suitable for subpopulations based upon their genetic composition.

2. Forensics DNA Testing Market
Testing DNA to create a physical profile of crime suspects is a new market based on evolving technologies. Common hereditary traits such as skin pigmentation, eye color, hair color, earlobe attachment and height can be predicted through analysis of DNA sequences. DNAPrintTM believes it is the first company to use DNA evidence to successfully profile a crime suspect by predicting that suspect’s continental origin.

3. Consumer DNA Products Market
There is an established market of consumers who recreationally research their genealogy and ancestral origin. Additionally, there is a market for paternity tests and other tests related to lineage. DNAPrintTM serves both of these consumer market segments through direct sales and independent distributors.

4. Contract Service Outsourcing Market
DNAPrintTM provides universities and drug discovery companies with genotyping services. The service provides our clients with the ability to screen efficiently and effectively for genes that may be responsible for certain human traits and/or disease states. (Source: http://www.dnaprint.com/)

Currently the share is traded at $0.015/share, which is unbelievably cheap. Obviously this is more like long-term investment since there are not a lot of companies are doing this technology yet. If you’re still not convinced that this company is a good investment, check out these news releases:

1. DNAPrint(TM) genomics, Inc. Agrees to Acquire Majority Ownership in German Pharmaceutical Company Biofrontera AG; Secures $35 Million Equity Commitment from Dutchess Private Equities Fund, L.P.
http://www.biospace.com/news_story.cfm?StoryID=17515920&full=1

2. DNAPrint Presents Forensics Discoveries; New Products Could Transform The Landscape Of DNA Testing
http://www.dnaprint.com/pr_6_27.htm

3. DNAPrint launches ‘ethnicity’ test
http://www.drugresearcher.com/news/news-NG.asp?id=54499

Quote of the Day:
If we find a company we like, the level of the market will not really impact our decisions. We will decide company by company. We spend essentially no time thinking about macroeconomic factors. – Warren Buffett

  • Share/Bookmark

Oct

9

Yes, I Finally Bought 1,000 Shares of Sciax Corp.

Filed Under Other | Leave a Comment

After reading these following articles, I’ve become more convinced that this company will be performing well in the long run.

NEWS: Sciax Announces Sale to U.S. Military

AY CITY, Mich. and TORONTO, Oct. 4, 2004 (PRIMEZONE) — Sciax Corp. (Other OTC:SCXC.PK – News) reported today that a U.S. military customer has placed a strategically significant evaluation order for a confidential defense product developed by Sciax R&D partner Eomax Corp.

Sciax in partnership with Eomax have worked for several years on the development of this electro-optical system and we are very pleased to place this initial evaluation unit,” stated Ralph Manore, Vice-President of Operations for Sciax.

“The process of creating unique technology solutions for use in challenging military environments is a major undertaking,” stated Ken Smart, President of Eomax. “The process of implementing these unique technology solutions into the war-fighting capabilities of any military force is, in many ways, an even bigger undertaking. This sale is a door-opener for the Sciax – Eomax partnership and we are confident that our technology can and will make a real difference for these military users.”

In addition to the Wolf Pack system, manufactured by Sciax under license from Eomax, the companies continue to work on several other projects. These projects include confidential efforts as well as publicly disclosed initiatives such as implementations of 3D imaging technology from Spatial View Inc. and continuing work with Richard Wolf GmbH.

The Sciax Wolf Pack is a highly modularized opto-electronic remote viewing system used by law enforcement and military personnel. The reconfigurable, multi-operational design of Wolf Pack makes the system ideal for many applications in physical security, drug and contraband interdiction, tactical response and protective security. Wolf Pack electronics and optical components are built to high standards of durability, allowing successful deployment in harsh conditions that would prohibit the use of many conventional imaging systems. (Source: Yahoo News)

NEWS: Sciax Reports That It Has Signed a Letter Of Intent to Acquire 50% Of Nuresco Polymers

BAY CITY, Michigan & TORONTO, Oct. 6, 2004 (PRIMEZONE) — Sciax Corp (Other OTC:SCXC.PK – News) reported today that it has signed a letter of intent to acquire 50% of Nuresco Polymers.

Nuresco (http://www.nuresco.net) has developed an advanced polymer system with strength, high service temperature, chemical resistance and other properties that allow it to effectively compete for contracts in the defence and aeronautics industries. “We are eager to explore the opportunity of working with Nuresco,” stated Ralph Manore, Vice President of Operations for Sciax. “It is expected that we may leverage Nuresco’s contact base as a number of high level introductions will be made available to advance sales of Sciax’s Wolf Pack into the defence industry,” added Mr. Manore.

“We are impressed with Sciax’s people and are excited by pursuing the excellent fit that the acquisition would provide for both our companies,” said P. Henry Naskali, Vice-President Business Development of Nuresco Polymers. “As well as being able to advance sales of Sciax products, we are also intrigued by the prospect of including our high performance light weight polymers into existing Sciax product lines as well as those under development,” stated Mr. Naskali. (Source: Yahoo News)

Quote of the Day: The market is there only as a reference point to see if anybody is offering to do anything foolish. When we invest in stocks, we invest in businesses. – Warren Buffett

  • Share/Bookmark

← Previous Page — Next Page →